Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS®) Real World Outcomes
The UPGRADE Study: Real World Outcomes® of Differential Target Multiplexed (DTM-SCS®) Stimulation in Existing and New Medtronic Implants
1 other identifier
observational
255
1 country
34
Brief Summary
The UPGRADE registry will capture long-term, real-world outcomes to understand the effect of Differential Target Multiplexed (DTM®) programming in the Spinal Cord Stimulation (SCS) implanted population on the management of chronic pain, primarily on its use for trunk and/or limb pain. The clinical study is sponsored by Celéri Health and is funded through a financial grant from Medtronic's External Research Program. The registry study will be conducted across approximately 25 centers in the United States with up to 600 participants enrolled.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Typical duration for all trials
34 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2021
CompletedFirst Posted
Study publicly available on registry
January 27, 2021
CompletedStudy Start
First participant enrolled
January 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedAugust 21, 2024
August 1, 2024
2.4 years
January 19, 2021
August 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the Pain Impact Score as measured by the PROMIS-29 before and after introduction of Differential Target Multiplexed (DTM®) stimulation programming in a real-world population.
24 months
Secondary Outcomes (6)
To characterize the responder rate for pain by pain area per Percent Pain Relief for DTM-SCS® compared to participant baseline treatment.
24 months
To characterize the responder rate for pain by pain area per Numeric Rating Scale for DTM-SCS® compared to participant baseline treatment.
24 months
To evaluate the longitudinal characterization of objective posture and activity measures.
24 months
To characterize Patient Global Impression of Change (PGIC) with neurostimulation.
24 months
To evaluate the performance of the DTM® pre-programming questionnaire in predicting outcome of DTM-SCS® programming.
24 months
- +1 more secondary outcomes
Interventions
Differential Target Multiplexed (DTM®) programming using Medtronic's Intellis™ or Vanta™ Spinal Cord Stimulation systems
Eligibility Criteria
Participant has a permanent Medtronic Intellis™ neurostimulation system implanted or is planning to be implanted with a Medtronic Intellis™ or Vanta™ neurostimulation system and is a candidate for Differential Target Multiplexed (DTM®) programming for the management of chronic pain, primarily on its use for trunk and/or limb pain.
You may qualify if:
- Participant must provide written informed consent prior to any clinical study-related procedure.
- Participant is at least 18 years (or the minimum age required by local law to consent for participation in a clinical investigation) or older at the time of enrollment.
- Participant has a permanent Medtronic Intellis™ neurostimulation system implanted or is planning to be implanted with a Medtronic Intellis™ or Vanta™ neurostimulation system.
- Participant has access to an iPhone or Android capable device and/or computer with regular internet access for the purposes of electronically completing web-based participant self-reported questionnaires via SMS text or email.
You may not qualify if:
- Participant is unable to provide written informed consent or to comply with study-related requirements, procedures, and visits.
- Participant is a profound responder for all pain areas to existing neurostimulation therapy (≥80% reported relief).
- Participant is enrolled, or intends to participate, in a clinical drug and/or device study (investigational device, investigational drug, new indication for a device or drug, or additional testing beyond standard of care procedures) which could confound the results of this trial as determined by the investigator.
- Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the participant's ability to participate in the clinical investigation or to comply with follow-up requirements.
- Participant is pregnant or nursing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Celéri Health, Inc.lead
- Medtroniccollaborator
Study Sites (34)
Neuroversion
Anchorage, Alaska, 99508, United States
Desert Sky Spine & Sports Medicine
Oro Valley, Arizona, 85755, United States
Desert Sky Spine & Sports Medicine
Sierra Vista, Arizona, 85635, United States
NuVation Pain Group - Buena Park
Buena Park, California, 90621, United States
NuVation Pain Group - Los Angeles
Los Angeles, California, 90020, United States
Spine and Sports Specialty Medical Group
Orange, California, 92801, United States
Spine & Nerve Diagnostic Center - Roseville
Roseville, California, 95661, United States
Florida Pain Medicine - Brandon
Brandon, Florida, 33511, United States
Jax Spine & Pain Centers - Fleming Island
Fleming Island, Florida, 32003, United States
Jax Spine & Pain Centers - UF North
Jacksonville, Florida, 32218, United States
Jax Spine & Pain Centers - Jacksonville
Jacksonville, Florida, 32256, United States
Florida Spine & Pain Specialists
Riverview, Florida, 33569, United States
Jax Spine & Pain Centers -St. Augustine
Saint Augustine, Florida, 32080, United States
Florida Pain Medicine - Wesley Chapel
Wesley Chapel, Florida, 33544, United States
National Spine and Pain Centers - Winter Park, FL
Winter Park, Florida, 32789, United States
Centurion Spine & Pain Centers (Jax Spine)
Waycross, Georgia, 31501, United States
Millennium Pain Center (National Spine and Pain Centers - Bloomington, IL)
Bloomington, Illinois, 61704, United States
National Spine and Pain Centers - National Harbor (Oxon Hill)
Oxon Hill, Maryland, 20745, United States
National Spine and Pain Centers - Pikesville, MD
Pikesville, Maryland, 21208, United States
Comprehensive and Interventional Pain Management
Henderson, Nevada, 89052, United States
National Spine and Pain Centers - The Pain Management Center - Voorhees
Voorhees Township, New Jersey, 08043, United States
Carolinas Research Institute - Mallard Creek
Charlotte, North Carolina, 28262, United States
Carolinas Research Institute - Huntersville
Huntersville, North Carolina, 28078, United States
Premier Pain Treatment Institute - Hillsboro
Hillsboro, Ohio, 45133, United States
Premier Pain Treatment Institute - Loveland
Loveland, Ohio, 45140, United States
Premier Pain Treatment Institute - Mt. Orab
Mount Orab, Ohio, 45154, United States
Oklahoma Pain Physicians - Norman
Norman, Oklahoma, 73072, United States
Oklahoma Pain Physicians - Oklahoma City
Oklahoma City, Oklahoma, 73120, United States
Oklahoma Pain Physicians - Purcell
Purcell, Oklahoma, 73080, United States
North Texas Orthopedics & Spine Center- Keller/Alliance
Fort Worth, Texas, 76244, United States
North Texas Orthopedics & Spine Center - Grapevine
Grapevine, Texas, 76051, United States
Precision Spine Care
Tyler, Texas, 75701, United States
Valley Pain Consultants
Winchester, Virginia, 22601, United States
Northwest Pain Care
Spokane, Washington, 99201, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michael Fishman, MD
Chief Medical Officer
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 24 Months
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 19, 2021
First Posted
January 27, 2021
Study Start
January 29, 2021
Primary Completion
July 1, 2023
Study Completion
July 1, 2023
Last Updated
August 21, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share